Bank of Montreal’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-134,396
| Closed | -$3.12M | – | 3943 |
|
|
2023
Q1 | $3.12M | Buy |
134,396
+11,541
| +9% | +$307K | ﹤0.01% | 1458 |
|
|
2022
Q4 | $3.5M | Buy |
+122,855
| New | +$3.46M | ﹤0.01% | 1494 |
|
|
2022
Q3 | – | Sell |
-174,999
| Closed | -$4K | – | 4044 |
|
|
2022
Q2 | $4K | Buy |
+174,999
| New | +$3.95M | ﹤0.01% | 1541 |
|
|
2021
Q2 | – | Sell |
-39,146
| Closed | -$2.07M | – | 3652 |
|
|
2021
Q1 | $2.07M | Sell |
39,146
-16,132
| -29% | -$799K | ﹤0.01% | 1789 |
|
|
2020
Q4 | $2.58M | Sell |
55,278
-24,106
| -30% | -$953K | ﹤0.01% | 1712 |
|
|
2020
Q3 | $2.82M | Buy |
79,384
+77,208
| +3,548% | +$3.38M | ﹤0.01% | 1512 |
|
|
2020
Q2 | $116K | Buy |
2,176
+616
| +39% | +$28.5K | ﹤0.01% | 3019 |
|
|
2020
Q1 | $58K | Sell |
1,560
-7,717
| -83% | -$357K | ﹤0.01% | 2826 |
|
|
2019
Q4 | $444K | Sell |
9,277
-12,038
| -56% | -$455K | ﹤0.01% | 2737 |
|
|
2019
Q3 | $691K | Buy |
21,315
+20,276
| +1,951% | +$839K | ﹤0.01% | 2256 |
|
|
2019
Q2 | $51K | Sell |
1,039
-2,961
| -74% | -$158K | ﹤0.01% | 3675 |
|
|
2019
Q1 | $270K | Sell |
4,000
-245
| -6% | -$14.3K | ﹤0.01% | 2581 |
|
|
2018
Q4 | $196K | Sell |
4,245
-1,012
| -19% | -$62.5K | ﹤0.01% | 2592 |
|
|
2018
Q3 | $405K | Sell |
5,257
-148
| -3% | -$11.9K | ﹤0.01% | 2419 |
|
|
2018
Q2 | $455K | Buy |
5,405
+545
| +11% | +$47.5K | ﹤0.01% | 2380 |
|
|
2018
Q1 | $397K | Buy |
4,860
+1,309
| +37% | +$101K | ﹤0.01% | 2320 |
|
|
2017
Q4 | $203K | Buy |
3,551
+1,520
| +75% | +$95.6K | ﹤0.01% | 2672 |
|
|
2017
Q3 | $135K | Sell |
2,031
-37
| -2% | -$2.22K | ﹤0.01% | 2843 |
|
|
2017
Q2 | $106K | Hold |
2,068
| – | – | ﹤0.01% | 2968 |
|
|
2017
Q1 | $121K | Buy |
2,068
+216
| +12% | +$10.4K | ﹤0.01% | 2722 |
|
|
2016
Q4 | $107K | Sell |
1,852
-7,571
| -80% | -$397K | ﹤0.01% | 2800 |
|
|
2016
Q3 | $498K | Buy |
9,423
+3,900
| +71% | +$170K | ﹤0.01% | 2089 |
|
|
2016
Q2 | $231K | Buy |
5,523
+5,023
| +1,005% | +$248K | ﹤0.01% | 2403 |
|
|
2016
Q1 | $20K | Sell |
500
-2,000
| -80% | -$85.5K | ﹤0.01% | 3396 |
|
|
2015
Q4 | $162K | Buy |
2,500
+1,483
| +146% | +$97.3K | ﹤0.01% | 2534 |
|
|
2015
Q3 | $72K | Sell |
1,017
-3,533
| -78% | -$345K | ﹤0.01% | 2765 |
|
|
2015
Q2 | $506K | Buy |
4,550
+800
| +21% | +$86.2K | ﹤0.01% | 1968 |
|
|
2015
Q1 | $354K | Sell |
3,750
-2,050
| -35% | -$230K | ﹤0.01% | 2108 |
|
|
2014
Q4 | $650K | Sell |
5,800
-100
| -2% | -$8.93K | ﹤0.01% | 1934 |
|
|
2014
Q3 | $362K | Buy |
5,900
+5,730
| +3,371% | +$247K | ﹤0.01% | 2245 |
|
|
2014
Q2 | $8K | Sell |
170
-2,830
| -94% | -$115K | ﹤0.01% | 3952 |
|
|
2014
Q1 | $117K | Buy |
+3,000
| New | +$100K | ﹤0.01% | 2726 |
|
Other funds holding AGIO
BG
AC
FCM
RSCM
Bank of Montreal's AGIO Position: Q2 2023 in Review
Bank of Montreal sold out of Agios Pharmaceuticals (AGIO) in Q2 2023, closing a stake of 134,396 shares — an estimated $3.12M sold.
Bank of Montreal first reported a position in AGIO in Q1 2014 and held it in 32 quarters. The position peaked at $3.5M in Q4 2022. 153 funds tracked by Wall St. Rank hold AGIO as of Q2 2023.
- Bank of Montreal reported no remaining Agios Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- Bank of Montreal sold 134,396 Agios Pharmaceuticals shares in Q2 2023, an estimated $3.12M.
- Bank of Montreal first reported a position in Agios Pharmaceuticals in Q1 2014 and held it in 32 quarters.
- Bank of Montreal's Agios Pharmaceuticals position peaked at $3.5M in Q4 2022.
- 153 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2023.
Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.